Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-42200
Titel: Neutrophil extracellular trap biomarkers in aneurysmal subarachnoid hemorrhage: early decline of DNase 1 activity associated with delayed cerebral ischemia
VerfasserIn: Hendrix, Philipp
Witsch, Jens
Spalart, Valérie
Schneider, Hauke
Oertel, Joachim
Geisel, Jürgen
Martinod, Kimberly
Hemmer, Sina
Sprache: Englisch
Titel: Frontiers in Neurology
Bandnummer: 15
Verlag/Plattform: Frontiers
Erscheinungsjahr: 2024
Freie Schlagwörter: subarachnoid hemorrhage
intracranial aneurysm
neutrophil extracellular traps
cellfree DNA
DNase activity
DDC-Sachgruppe: 610 Medizin, Gesundheit
Dokumenttyp: Journalartikel / Zeitschriftenartikel
Abstract: Introduction: High-mobility group box 1 (HMGB1) protein is a critical mediator of neutrophil extracellular trap (NET) formation (NETosis). Myeloperoxidase (MPO)- DNA complexes, a biomarker of NETs, and HMGB1 have been associated with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Additional mechanistic NET-related biomarkers and their role in the neuroinflammatory cascade surrounding DCI remain to be explored. Methods: A post-hoc analysis of a prospective, blinded, single-center biomarker observational study was performed. De novo measurements of serum citrullinated histone H3-DNA complexes (H3Cit-DNA), peptidylarginine deiminase 4 (PAD4), cell-free DNA (cf-DNA), and DNase 1 activity were conducted on admission (D0) and day 4 (D4). Delayed cerebral infarction (DCI) was defined as new cerebral infarction on CT head not present on the post-treatment scan. Results: H3Cit-DNA, PAD4, cf-DNA, and DNase 1 activity were within quantifiable ranges in all serum samples analyzed at D0 and D4. Admission biomarker levels were not associated with DCI development. From D0 to D4, in both the DCI and the non-DCI groups, H3Cit-DNA levels significantly decreased, cf-DNA levels significantly increased, and PAD4 levels remained stable. In contrast, DNase 1 activity significantly decreased from D0 to D4 in the DCI group (p  <  0.001) but not in the non-DCI group. Conclusion: This exploratory analysis demonstrated NET-related biomarkers such as H3Cit-DNA, PAD4, cf-DNA, and DNase 1 activity in all aSAH patients. A decline of systemic DNase 1 activity in the early phase might increase the risk of delayed cerebral ischemia.
DOI der Erstveröffentlichung: 10.3389/fneur.2024.1354224
URL der Erstveröffentlichung: https://doi.org/10.3389/fneur.2024.1354224
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-422007
hdl:20.500.11880/37871
http://dx.doi.org/10.22028/D291-42200
ISSN: 1664-2295
Datum des Eintrags: 17-Jun-2024
Fakultät: M - Medizinische Fakultät
Fachrichtung: M - Innere Medizin
M - Neurochirurgie
Professur: M - Prof. Dr. Jürgen Geisel
M - Prof. Dr. Joachim Oertel
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Datei Beschreibung GrößeFormat 
fneur-15-1354224.pdf779,76 kBAdobe PDFÖffnen/Anzeigen


Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons Creative Commons